Clinical Trials Act 2011Section 18
18. The sponsor
(1) Subject to the approval of the Council, a sponsor and an
investigator may be the same person.
(2) Every sponsor shall comply with the terms and conditions of
any trial licence issued to him.
(3) Every sponsor shall designate an investigator who shall be
based in Mauritius and be responsible for the conduct of the trial within
Mauritius.
(4) Every sponsor shall be responsible for implementing and
maintaining quality assurance and quality control systems with written
standard operating procedures.
(5) A sponsor of a clinical trial shall notify the Council in writing
of any serious breach of –
(a) the conditions and principles of good clinical practice
in connection with that trial; or
(b) the trial licence issued by the Council.
Acts 2011 111
(6) For the purpose of this section, “serious breach” means a
breach which is likely to affect to a significant degree –
(a) the safety or physical or mental integrity of a subject; or
(b) the scientific value of a clinical trial.